clinical trial

Phase 3 Clinical Trial for Eteplirsen Now Enrolling Boys with Duchenne Muscular Dystrophy

Boys with Duchenne muscular dystrophy between the ages of seven and 16 are now being recruited to participate in a phase 3 clinical trial to evaluate the effectiveness and safety of eteplirsen in treating DMD.

LEMS: Firdapse Study Shows Encouraging Results

DMD: Sarepta Updates Community on Eteplirsen, Other Compounds

MG: Multicenter Trial of Rituximab Opens

First Drug for Duchenne Muscular Dystrophy Gets 'Conditional Approval' in Europe

DMD: Ataluren Receives Conditional Approval in Europe

ISIS-SMNRx to Be Tested in Phase 3 Trial in Infants With SMA

DMD: ReveraGen Drug Will Move to Human Testing

International Consortium Provides $2M Funding for Phase 1 Clinical Trial of ReveraGen DMD Drug

DMD: Ataluren May Get Conditional Approval in Europe

MDA in Your Community


Grants